ProCE Banner Activity

The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum

Slideset

Download this slide set to review strategies on how to incorporate SGLT2 inhibitors into a variety of heart failure patients with varying ejection fractions.

Released: October 04, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company